Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Botulinum Toxin A approved by the Food and Drug Administration in 2022.
| Trade Name and Active Ingredient |
Class | Target/Mechanism of Action | Original Approval Date | Manufacturer | Therapeutic Indication |
|---|---|---|---|---|---|
| DaxxifyTM (daxibotulinum- toxin A) [3,81] |
Botulinum toxin A (protein-based therapy) | Inhibits the release of Acetylcholine to the Neuromuscular Junction |
7 September 2022 | Revance Therapeutics, Inc. | Improve glabellar lines associated with corrugator and/or procerus muscle activity |
